MILVEXIAN FOR PREVENTION AND TREATMENT OF THROMBOEMBOLIC DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20250099466A1
SERIAL NO

18692560

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The factor Xia inhibitor milvexian has therapeutic properties useful in the treatment and/or prevention of thrombotic and thromboembolic disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN PHARMACEUTICA NVTURNHOUTSEWEG 30 2340 BEERSE 2340

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHINTALA, Madhu Springhouse, US 8 54
JONES-BURTON, Charlotte Princeton, US 1 0
LI, Danshi Princeton, US 1 0
LUETTGEN, Joseph M Princeton, US 2 0
NESSEL, Christopher Bridgewater, US 1 0
PERERA, Liyanage Vidya Princeton, US 1 0
PETERS, Gary Raritan, US 23 2186
SEIFFERT, Dietmar Alfred Princeton, US 2 12
STRONY, John Raritan, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation